Plenco 308

Product Description

Plenco 308 was a phenolic molding compound manufactured by Plenco (Plastics Engineering Company), a Wisconsin-based specialty chemicals and plastics manufacturer with a long history of producing thermosetting resin systems for industrial applications. Phenolic molding compounds of this type were widely used throughout American manufacturing during the mid-to-late twentieth century, prized for their heat resistance, dimensional stability, and electrical insulating properties.

Products in the Plenco line were engineered for demanding industrial environments where conventional thermoplastics could not withstand sustained elevated temperatures or mechanical stress. Plenco 308 was among the formulations intended for use in molded industrial components—parts that required a material capable of maintaining structural integrity under thermal and chemical exposure. Applications for phenolic compounds of this class included electrical housings, automotive components, industrial hardware, and equipment parts used in manufacturing facilities across numerous sectors.

Plastics Engineering Company supplied its molding compounds to fabricators, molders, and industrial manufacturers who processed the raw compound material into finished parts through compression molding, transfer molding, or injection molding techniques. The compound form—typically a granular or powdery feedstock—was handled by workers both at the point of manufacture and at downstream processing facilities.

Asbestos Content

Phenolic molding compounds produced during certain periods of industrial manufacturing incorporated asbestos fibers as a filler or reinforcing agent. Asbestos was valued in thermosetting compound formulations because it enhanced heat resistance, improved dimensional stability during the curing process, reduced shrinkage, and provided additional mechanical strength to finished molded parts. These properties made asbestos-containing phenolic compounds particularly attractive for applications involving elevated temperatures or electrical insulation requirements.

Litigation records document allegations that Plenco 308 contained asbestos as a component of its formulation. Plaintiffs alleged that asbestos fibers—most commonly chrysotile, though amphibole varieties were sometimes used in industrial compound formulations of this era—were present in the compound material and were released during routine handling, processing, and machining of products made with or from this compound.

The specific asbestos content by weight in phenolic molding compounds varied by formulation and production period. Regulatory frameworks such as AHERA (Asbestos Hazard Emergency Response Act) and OSHA’s asbestos standards recognize that materials containing as little as one percent asbestos by weight can pose a significant inhalation hazard, and that fiber release is particularly associated with dry, friable, or powdered materials—characteristics inherent to phenolic molding compound feedstocks before and during processing.

How Workers Were Exposed

Workers exposed to Plenco 308 and similar phenolic molding compounds were primarily those involved in the industrial manufacturing and processing pipeline for molded parts. Litigation records document that exposure occurred at multiple stages of the product’s lifecycle, from compound handling to secondary machining of finished components.

Compound Handlers and Molding Press Operators were among those most directly exposed. The raw phenolic molding compound, in granular or powdered form, generated airborne dust during weighing, transferring, loading into molds, and general handling. Plaintiffs alleged that this dust contained respirable asbestos fibers that workers inhaled during the course of ordinary job duties without adequate respiratory protection or engineering controls.

Compression and Transfer Molders who operated presses to form parts from the compound material encountered dust and off-gases during the pressing and curing cycle. The heat and pressure involved in the molding process could further disturb compound material and contribute to fiber release in the immediate work environment.

Machinists and Fabricators who performed secondary operations on finished phenolic molded parts—including drilling, grinding, cutting, sanding, and trimming—were also documented as potentially exposed. Litigation records note that machining operations on asbestos-containing molded parts generated fine particulate debris that could become airborne and remain suspended in workplace air for extended periods.

Maintenance Workers and Plant Employees in facilities where phenolic molding operations were conducted may have experienced secondary or bystander exposure through the general contamination of workplace air and surfaces, even when not directly involved in molding or machining tasks.

Industrial workers generally—a broad category that reflects the widespread use of phenolic compounds across American manufacturing—formed the core population of potentially exposed individuals documented in litigation. Many of these workers labored in facilities where multiple asbestos-containing products were in concurrent use, compounding cumulative exposure burdens over careers that often spanned decades.

OSHA’s current permissible exposure limit (PEL) for asbestos is 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, with an excursion limit of 1.0 f/cc over a thirty-minute period. Workplace conditions that existed during the primary period of Plenco 308’s production and use predate these modern standards, and industrial hygiene controls that are now considered standard practice were frequently absent or inadequate in facilities where compound processing occurred.

Plenco 308 is classified as a Tier 2 product for legal purposes, meaning that claims arising from exposure to this product are addressed through civil litigation rather than through a dedicated asbestos bankruptcy trust fund. Plastics Engineering Company has not, based on available records, established or contributed to an asbestos settlement trust of the type created under Section 524(g) of the U.S. Bankruptcy Code.

Civil Litigation

Plaintiffs alleging injury from exposure to Plenco 308 have pursued claims through the civil court system. Litigation records document cases in which individuals diagnosed with asbestos-related diseases—including mesothelioma, asbestosis, lung cancer, and other asbestos-attributable conditions—named Plenco or its successor entities as defendants based on alleged exposure to the company’s phenolic molding compound products.

Plaintiffs alleged that Plenco knew or should have known of the hazards associated with asbestos-containing compounds and failed to adequately warn workers, downstream processors, and end users of those risks. Claims have proceeded under theories of negligence, strict products liability, and failure to warn.

Multi-Defendant Litigation Strategy

Because industrial workers in manufacturing settings typically encountered numerous asbestos-containing products over the course of their careers, litigation arising from exposure to Plenco 308 often involves multiple defendants. A qualified asbestos attorney can assess the full scope of a claimant’s occupational history to identify all potential sources of exposure and all responsible parties—which may include manufacturers of other compounds, equipment, and materials used in the same facilities.

Who May Have Legal Standing

Individuals who worked as molding press operators, compound handlers, machinists, or general industrial workers in facilities that processed or used Plenco 308, and who have been diagnosed with mesothelioma, lung cancer, asbestosis, or pleural disease, may have legal standing to pursue a claim. Family members of deceased workers may be eligible to file wrongful death actions under applicable state law.

Asbestos-related diseases frequently have latency periods of twenty to fifty years between first exposure and clinical diagnosis, meaning that workers exposed during the 1950s through 1980s may be receiving diagnoses today. Statutes of limitations for asbestos claims vary by state and typically begin running from the date of diagnosis or discovery of the disease rather than the date of exposure. Prompt consultation with an attorney experienced in asbestos litigation is advisable to preserve legal rights.